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Development of a 32P-Postlabeling Assay
for 7-Methylguanines in Human DNA
by Riitta Mustonen,' Asta Forsti, Paivi Hietanen,2
and Kari Hemminki"3
Theapplicationofa32P-postlabeling assayfor7-methylguaninesinDNA wasstudiedeitherbylabelingtheimidazole
ring-openeddimncleotidederivatives orbyusingstrong-anion-cchangecolumnchromatography fortheadductenrichment
from normal nucleotides. Data showed that 7-methylguanines can be efficiently labeled asdinucleotides when in vitro
methylated DNA was first imidazole ring-opened and then digested tothe dinucleotide level withdeoxyribonuclease I,
snake venom phosphodiesterase, andprostatic acidphosphatase. Whenusingionexchangechromatography forthead-
duct enrichment, DNA was digested with micrococcal nuclease and spleen phoshodiesterase. Anion exchange
chromatography wasapplied for7-methylguanine measurements in white blood cell DNAofhealthy nonsmokers (n =
17) and patients (n = 4)treatedwiththemethylatingdrugsprocarbazineanddacarbazine. IVWfoundthatthe meanlevel
of7-methylguanine residues in nonsmokers was2.5 per 10' nucleotides. Thecorresponding level inthe patientsamples
immediately after the drug treatment was 57 per 107 nucleotides.
Introduction
The 32P-postlabeling assay has been used mainly in the
analysis oflarge, nonpolar DNA adducts (1,2). There are few
studies on the labeling ofsmall alkyl adducts, particularly N7
guanine adducts (1,3). Theproblems relating to the stability of
the N7 alkylation products can be solved by imidazole ring-
opening inalkali (4). Inthepresentstudy, amethod to measure
ring-opened7-methylguanines asdinucleotides wasdeveloped.
Anionexchange chromatography wasalsoused fortheisolation
of7-methylguanine nucleotides from normal nucleotides. By us-
ing this enrichment procedure, the levels of7-methylguanines
were determined in healthy individuals as well as in cancer pa-
tients receiving the methylating agents dacarbazine and pro-
carbazine.
Determination of7-MethylguaninesAs
Dinucleotides
2 '-Deoxyguanylyl(3 '-5')-thymidine (dGpdT; P-L Biochem-
icals) andthymidylyl(3 '-5 )-2'-deoxyguanosine(dTpdG; Sigma)
were methylated atthe N7 positionofguanineby reacting with
dimethyl sulfate (DMS; Fluka). The reaction products were
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purified by HPLC, lyophilized, and the imidazole ring ofthe
7-Methylguanine moiety was opened by alkali treatment.
7-Methylated dGpdT and dTpdG (Me-dGpdT, dTpdG-Me,
respectively) and ring-opened 7-methylated dTpdG (dTpdG-
ROM) were labeled quantitatively at femtomole levels. With
ring-opened 7-methylated dGpdT (ROM-dGpdT), the limit of
detection and the labeling efficiency were two orders of
magnitudelower. Becauseoftheseresult, wesearchedenzymes
that would cutROM-dGpdT but notdTpdG-ROM.
The efficiency of the enzymatic digestion was first tested
separately with each ofthe enzymes DNAse I (Fluka), deoxy-
ribonuclease II (DNase II; Sigma), micrococcal nuclease
(Sigma), nuclease PI (Boehringer, Mannheim), nuclease SI
(Sigma), prostatic acid phosphatase (Sigma), spleen phos-
phodiesterase (Boehringer, Mannheim)andsnakevenomphos-
Table 1. Efficiency oftheT4 polynucleotide kinase reaction of
ROM-dGpdT, dTpdG-Me, anddTpdG-ROM.
No. of %
Adduct Treatment experiments Recovery
ROM-dGpdT ± DNA + enzymes 1 0
dTpdG-Me ± DNA + enzymes 1 0
dTpdG-Me DNA(1:4)a+ NaOH + enzymes 1 101
dTpdG-Me DNA(1:50)a+ NaOH + enzymes 1 83
dTpdG-ROM - 2 91/100b
dTpdG-ROM Enzymes 2 31/56b
dTpdG-ROM DNA(1:4)a+ enzymes 2 31/48b
dTpdG-ROM DNA(1:50)a+ enzymes 2 33/56b
Abbreviations: ROM, ring-opened methylated; Me, methylated; dGpdT,
2'-deoxyguanylyl(3'-5')-thymidine; dTpdG, thymidylyl(3'-5)-2'-deoxy-
guanosine.
aMe-guanine: DNA nucleotides.
bThe results oftvo experiments.MUSIONENETAL.
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FIGURE 1. Two-dimensional resolutionof32P-labeled dinucleotide adducts fromunmodified calfthymus DNA (A) and methylated DNA (B) afteralkali treatment
and enzymatic digestion. Ycorresponds toring-openedmethylated2'-deoxyguanylyl(3 '-5 )-thymidine, and R, S, andTcorrespond tootheralkali-treatedmethylated
dinucleotides. 0, origincontaining radioactive ATP: a,orthophosphate; b, unidentifiedphosphorylationproductformed inthe incubationbuffercontaining the
enzyme but nodinucleotide. ID indicates thefirstdimensionand2Dthe seconddimensionoftheTLC. The firstdimension wasdeveloped in0.2 M ammonium
nitrate and 1% acetic acid and the second dimension in 0.5 M LiCl. Autoradiography was for 14 hr.
phodiesterase (Sigma). Theonly enzymethatdigesteddTpdG-
Me and that did not digest dTpdG-ROM was snake venom
phosphodiesterase. The mixture of enzymes DNAse I, snake
venom phosphodiesterase, andprostatic acidphosphatasecom-
pletely digested ROM-dGpdTanddTpdG-Me withandwithout
added DNA, butitdidnotmarkedlydigestdTpdG-ROMwithor
without added DNA (Table 1).
Preliminary experiments werecarriedoutinthesamemanner
to digest methylated and ring-opened methylated DNA (Me-
DNA, ROM-DNA, respectively). Me-DNA was completely
digested, but with ROM-DNA fouradduct spots were found in
the autoradiogram ofatwv-dimensional TLC (Fig. 1). The ad-
ductsco-migrated with themethylated, alkali-treated mixtureof
dTpdG, 2'-deoxycytidylyl(3 '-5 ')-2'-deoxyguanosine(dCpdG),
2'-deoxyadenylyl(3'-5')-2'-deoxyguanosine (dApdG), and
2 '-deoxyguanylyl(3 '-5')-2'-deoxyguanosine (dGpdG).
7-MethylguanineLevelsinWhite Blood
Cell DNA of Healthy Individuals and
Cancer Patients Treated with
Methylating Agents
Differentprepurificationmethodologies havebeenapplied for
small alkyl DNA adducts (2-6). Inpresent study, an anion ex-
change cartridge enrichment, which elutes the uncharged 7-
alkylguanine residues inthe void volume and retains the nega-
tively charged normal nucleotides, was chosen for human
samples (5).
Cancer patients, 24-77 years old, had undergone chemo-
therapy withdacarbazineorprocarbazine forseveraldays. The
diseases weremelanoma,lymphoma, andHodgkin'sdiease. The
blood wasdrawnattheendoftheregimen. Thecumulativedoses
at the end ofthe treatment varied between 1050 and 2800 mg
(Table 2). All the patients were at least occasional smokers.
Table2. 7-Methylguaninelevels in whiteblood cell DNAofcancer
patients treated with methylating agentsand incontrol individuals.
Daily dose, Totaldose, No. analyses/ Adducts/107
Patients Treatment mg mg individual nucleotides+SD
I D 300 1200 6 28 + 11
2 p 150 1200 4 70 35
3 p 200 2800 2 97 43
5 p 150 1050 2 31 I
Total 57 + 33
Controls
1-17 - - - 1 or 2 2.4(0.5-9.0)'
aD, dacarbazine; P, procarbazine.
bThe results were corrected by a factor of2 for loss in preparation.
CRange in parentheses.
FIGURE 2. Two-dimensional separation of phosphorylated 7-methylated-
dGMPstandard (X) inpanel (A); sample fromaprocarbazine-treatedpatient
(B); and control person (C). P, orthophosphate.
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The application of a two-dimensional TLC system to phos-
phorylated human samples is shown in Figure 2. The result
showed abackground level of7-Me-dGMP inall the 17 normal
healthy, nonsmoking individuals studied. However, thepatients
undergoing chemotherapywith methylating agentshad some20
times higherlevelsof7-methylguaninein DNAthanthehealthy
individuals (Table2). Harrisandco-workers reported7-methyl-
guanine levels in lung tissue at 10-50adducts per 107 guanines
(7). Datafor06-methylguanine frompatients treatedwithpro-
carbazine and dacarbazine gave adduct levels up to 18 and 28
methylguanines/107 nucleotides, respectively (8,9). Thisagrees
withourdatabecausetheproportionof06/N7methylguanine in
ratDNA afteraprocarbazinedosagewas showntobeabout0.1
(10). One has tobecautious, however, inthecomparisonofad-
ducts with different repair kinetics.
This manuscript was presented asaposterattheConferenceonBiomonitor-
ing and Susceptibility Markers in Human Cancer: Applications in Molecular
Epidemiology and Risk Assessment that washeld in Kailua-Kona, Hawaii, 26
October-I November 1991.
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